Cabozantinib 20 mg Tablet . Cabometyx® for Kidney, Liver & Thyroid Cancer
Caboxen 20 contains Cabozantinib 20 mg, an oral targeted anti-cancer medicine belonging to the Tyrosine Kinase Inhibitor (TKI) class. It is designed to interfere with multiple signaling pathways that promote tumor growth, blood vessel formation, and cancer spread.
Manufactured by Everest Pharmaceuticals, Caboxen 20 is supplied in convenient tablet form and is intended for use under the supervision of an oncology specialist.
Mechanism of Action of Cabozantinib 20 mg Tablet
Cabozantinib works by inhibiting several receptor tyrosine kinases involved in cancer progression, including:
- VEGFR (Vascular Endothelial Growth Factor Receptor)
- MET Receptor
- AXL Receptor
By blocking these pathways, Cabozantinib helps:
- Slow tumor growth
- Reduce tumor blood supply (angiogenesis)
- Limit cancer cell invasion and metastasis
- Support disease control in selected advanced cancers
Therapeutic Indications of Cabozantinib 20 mg Tablet
Caboxen 20 may be prescribed for the treatment of:
- Advanced Renal Cell Carcinoma (RCC)
- Hepatocellular Carcinoma (HCC)
- Advanced or Metastatic Differentiated Thyroid Cancer (DTC)
Treatment decisions should always follow current clinical guidelines and oncologist recommendations.
Dosage & Administration
| Parameter | Information |
|---|---|
| Strength | Cabozantinib 20 mg |
| Dosage Form | Oral Tablet |
| Usual Administration | Once daily |
| Food Requirement | Take on an empty stomach |
| Tablet Handling | Swallow whole with water |
| Dose Adjustment | As determined by the treating oncologist |
Safety Information
- Use only under medical supervision
- Not recommended during pregnancy unless clearly indicated
- Breastfeeding should be avoided during treatment
- Routine monitoring of blood pressure and liver function is recommended
- Avoid grapefruit and grapefruit-containing products during therapy
- Inform healthcare providers about all current medications
International Supply Information
- Prescription-only oncology medicine
- Available for international sourcing and export
- Regulatory documentation may be provided according to destination-country requirements
- Suitable for regulated and semi-regulated pharmaceutical markets
Frequently Asked Questions
Is Cabozantinib 20 mg Tablet a chemotherapy medicine?
No. Caboxen 20 is a targeted therapy that belongs to the tyrosine kinase inhibitor (TKI) class and works differently from conventional chemotherapy.
What cancers can Caboxen 20 be used for?
It is commonly used in selected cases of kidney cancer, liver cancer, and advanced differentiated thyroid cancer.
Can Caboxen 20 be used for long-term treatment?
Treatment duration depends on patient response, tolerability, and the oncologist’s assessment.
How should Caboxen 20 be taken?
It is generally taken once daily on an empty stomach as directed by a healthcare professional.
Product Summary
Caboxen 20 is a targeted oncology treatment containing Cabozantinib 20 mg, developed to help manage advanced kidney, liver, and thyroid cancers by inhibiting multiple cancer-growth pathways. It is available for international pharmaceutical supply and export from Bangladesh.
